Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery
-
Published:2023-02
Issue:
Volume:210
Page:105506
-
ISSN:0166-3542
-
Container-title:Antiviral Research
-
language:en
-
Short-container-title:Antiviral Research
Author:
Chiu WinstonORCID,
Schepers Joost,
Francken Thibault,
Vangeel Laura,
Abbasi Kayvan,
Jochmans Dirk,
De Jonghe Steven,
Thibaut Hendrik Jan,
Thiel Volker,
Neyts Johan,
Laporte Manon,
Leyssen PieterORCID
Subject
Virology,Pharmacology
Reference45 articles.
1. “The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern,”;Abdelnabi;Nat. Commun.,2022
2. Small-molecule antiviral β-d-N4-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance;Agostini;J. Virol.,2019
3. “Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2,”;Baggen;Nat. Genet.,2021
4. “Drug repurposing screens identify chemical entities for the development of COVID-19 interventions,”;Bakowski;Nat. Commun.,2021
5. “Synthesis, structure-activity relationships, and antiviral profiling of 1-heteroaryl-2-alkoxyphenyl analogs as inhibitors of SARS-CoV-2 replication,”;Bardiot;Molecules,2022
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献